Date | Time | Source | Headline | Symbol | Company |
01/03/2012 | 8:00AM | Marketwired | Poniard Pharmaceuticals Common Stock to Be Delisted From Nasdaq Stock Market, Intention to List on OTC Bulletin Board | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
12/23/2011 | 3:37PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
11/22/2011 | 2:13PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
11/21/2011 | 1:15PM | Marketwired | Poniard Pharmaceuticals Announces Shareholders Approve Merger With ALLOZYNE | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
11/21/2011 | 9:00AM | Marketwired | Steps in the Right Direction - Featured Research on Poniard Pharmaceuticals, Inc. and Gilead Sciences, Inc. | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
11/18/2011 | 1:00PM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
11/18/2011 | 8:30AM | Marketwired | Poniard Pharmaceuticals Announces Licensing Agreement for Focal Adhesion Kinase Technology | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
11/10/2011 | 2:54PM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
11/09/2011 | 1:16PM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
11/09/2011 | 8:30AM | Marketwired | ISS Proxy Advisory Services Recommends Poniard Shareholders Vote "FOR" Poniard's Proposed Merger With ALLOZYNE and Reverse St... | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
11/08/2011 | 6:05AM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
11/07/2011 | 8:30AM | Marketwired | Glass Lewis Recommends Poniard Shareholders Vote "FOR" Poniard's Proposed Merger With ALLOZYNE and Reverse Stock Split | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
11/04/2011 | 6:10AM | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(3) (424B3) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
11/02/2011 | 4:01PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
10/28/2011 | 4:16PM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
10/28/2011 | 4:01PM | Marketwired | Poniard Pharmaceuticals Reports Third Quarter 2011 Financial Results | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
10/28/2011 | 1:59PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
10/28/2011 | 11:19AM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
10/28/2011 | 8:30AM | Marketwired | Egan-Jones Recommends Poniard Shareholders Vote "FOR" Poniard's Proposed Merger With ALLOZYNE and Reverse Stock Split | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
10/24/2011 | 3:47PM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
10/21/2011 | 2:00PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
10/12/2011 | 1:43PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
10/12/2011 | 1:41PM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
10/12/2011 | 1:37PM | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(3) (424B3) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
10/11/2011 | 9:10AM | Dow Jones News | Registration Effectiveness Orders Issued By The SEC | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
10/11/2011 | 6:00AM | Edgar (US Regulatory) | Notice of Effectiveness (EFFECT) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
10/07/2011 | 5:43PM | Marketwired | Poniard Pharmaceuticals Announces Effectiveness of Form S-4 Registration Statement for the Proposed Merger with ALLOZYNE | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
10/07/2011 | 5:27PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
10/07/2011 | 5:26PM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
10/07/2011 | 1:22PM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |